| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $20.3M | — | +62.0% |
| SG&A Expense | $2.0M | — | -42.6% |
| Operating Income | -$22.4M | — | -39.2% |
| Pre-tax Income | -$21.8M | — | -39.0% |
| Income Tax | $373K | — | — |
| Net Income | -$22.1M | — | -41.4% |
| EPS (Basic) | -$1.24 | — | +9.5% |
| EPS (Diluted) | -$1.24 | — | +9.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $58.2M | -24.3% | +27.0% |
| Current Assets | $65.1M | -19.2% | +38.1% |
| Total Assets | $67.2M | -18.8% | +41.6% |
| Current Liabilities | $23.6M | +14.0% | +161.8% |
| Total Liabilities | $25.1M | +15.3% | — |
| Stockholders' Equity | $42.1M | -31.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.8M | — | -81.6% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | -100.0% |
| Financing Cash Flow | $74K | — | +103.2% |
| Free Cash Flow | -$18.8M | — | -80.6% |
| +9.6% |